These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 730830)

  • 21. Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
    Carlsson J; Wrethén J; Beckman G
    J Clin Microbiol; 1977 Sep; 6(3):280-4. PubMed ID: 332713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteroides and appendicitis (author's transl)].
    Werner H; Kunstek-Santos H; Schockemöhle C; Gündürewa M
    Pathol Microbiol (Basel); 1975; 42(2):110-8. PubMed ID: 1178229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of clinical isolates of selected species of Bacteroides: production of phenylacetic acid.
    Mayrand D
    Can J Microbiol; 1979 Aug; 25(8):927-8. PubMed ID: 526889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the bacteroides fragilis group.
    DeGirolami PC; Mepani CP
    Am J Clin Pathol; 1981 Jul; 76(1):78-82. PubMed ID: 7020409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
    Brook I; Frazier EH
    Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of randomly cloned DNA fragments for identification of Bacteroides thetaiotaomicron.
    Salyers AA; Lynn SP; Gardner JF
    J Bacteriol; 1983 Apr; 154(1):287-93. PubMed ID: 6833179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
    Reig M; Campello MG; Baquero F
    J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of oxygen on endotoxin production in bacteria of the Bacteroides fragilis group isolated from patients with colorectal carcinoma].
    Chmelař D; Hájek M; Janečková J; Vobejdová J; Martineková P; Kašíková A
    Epidemiol Mikrobiol Imunol; 2016; 65(2):129-35. PubMed ID: 27467330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent antibody test kit for rapid detection and identification of members of the Bacteroides fragilis and Bacteroides melaninogenicus groups in clinical specimens.
    Holland RW; Stauffer LR; Altemeier WA
    J Clin Microbiol; 1979 Aug; 10(2):121-7. PubMed ID: 41847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of Bacteroides ovatus and Bacteroides thetaiotaomicron by means of bacteriophage.
    Cooper SW; Szymczak EG; Jacobus NV; Tally FP
    J Clin Microbiol; 1984 Dec; 20(6):1122-5. PubMed ID: 6520221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.
    Walker CB; Wilkins TD
    Infect Immun; 1976 Sep; 14(3):721-5. PubMed ID: 965094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregation by fragilis and non-fragilis Bacteroides strains in vitro.
    Blake M; Rotstein OD; Llano M; Girotti MJ; Reid G
    J Med Microbiol; 1989 Jan; 28(1):9-14. PubMed ID: 2536442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of phenylacetic acid by Bacteroides melaninogenicus ssp. intermedius serogroup C-1.
    Ferguson KP; Mayberry WR; Lambe DW
    Can J Microbiol; 1983 Feb; 29(2):276-9. PubMed ID: 6133607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.